BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 28177129)

  • 1. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-/-) and Parp-2(-/-) mice with lung cancer cachexia.
    Chacon-Cabrera A; Fermoselle C; Salmela I; Yelamos J; Barreiro E
    Biochim Biophys Acta; 2015 Dec; 1850(12):2530-43. PubMed ID: 26432600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the beta
    Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
    Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema.
    Salazar-Degracia A; Blanco D; Vilà-Ubach M; de Biurrun G; de Solórzano CO; Montuenga LM; Barreiro E
    J Transl Med; 2016 Aug; 14(1):244. PubMed ID: 27549759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.
    Barreiro E; Puig-Vilanova E; Marin-Corral J; Chacón-Cabrera A; Salazar-Degracia A; Mateu X; Puente-Maestu L; García-Arumí E; Andreu AL; Molina L
    J Cell Physiol; 2016 Jul; 231(7):1495-513. PubMed ID: 26530247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
    Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
    J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy.
    Plant PJ; Bain JR; Correa JE; Woo M; Batt J
    J Appl Physiol (1985); 2009 Jul; 107(1):224-34. PubMed ID: 19390003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia.
    Penedo-Vázquez A; Duran X; Mateu J; López-Postigo A; Barreiro E
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.
    Op den Kamp CM; Langen RC; Snepvangers FJ; de Theije CC; Schellekens JM; Laugs F; Dingemans AM; Schols AM
    Am J Clin Nutr; 2013 Sep; 98(3):738-48. PubMed ID: 23902785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
    Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
    Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.
    McClung JM; Judge AR; Powers SK; Yan Z
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C542-9. PubMed ID: 19955483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.
    Oláh G; Szczesny B; Brunyánszki A; López-García IA; Gerö D; Radák Z; Szabo C
    PLoS One; 2015; 10(7):e0134227. PubMed ID: 26218895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice.
    Mateu-Jiménez M; Cucarull-Martínez B; Yelamos J; Barreiro E
    Biochimie; 2016 Feb; 121():278-86. PubMed ID: 26700152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP-1 and PARP-2 activity in cancer-induced cachexia: potential therapeutic implications.
    Barreiro E; Gea J
    Biol Chem; 2018 Jan; 399(2):179-186. PubMed ID: 29016348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
    Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.